https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-14 / Front Immunol 2019;10:1939
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-14 / Front Immunol 2019;10:19392019-08-14 00:00:002023-03-07 12:33:09Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-09 / J Extracell Vesicles 2019;8(1):1648995
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-09 / J Extracell Vesicles 2019;8(1):16489952019-08-09 00:00:002020-08-31 08:17:52Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-08 / Front Immunol 2019;10:1832
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-08 / Front Immunol 2019;10:18322019-08-08 00:00:002019-08-08 00:00:00A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-07 / World J Gastroenterol 2019 Aug;25(29):3941-3955
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-07 / World J Gastroenterol 2019 Aug;25(29):3941-39552019-08-07 00:00:002019-08-07 00:00:00Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-3663
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-36632019-07-21 00:00:002019-07-21 00:00:00Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-18 / Oncoimmunology 2019;8(11):e1638212
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-18 / Oncoimmunology 2019;8(11):e16382122019-07-18 00:00:002019-07-18 00:00:00Trial watch: dendritic cell vaccination for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-3167
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-31672019-07-07 00:00:002019-07-07 00:00:00Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-28 / World J. Gastroenterol. 2019 Jun;25(24):2977-2989
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-28 / World J. Gastroenterol. 2019 Jun;25(24):2977-29892019-06-28 00:00:002019-06-28 00:00:00Immunotherapy for hepatocellular carcinoma: Current and future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-22 / Cancers (Basel) 2019 Jun;11(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-22 / Cancers (Basel) 2019 Jun;11(6)2019-06-22 00:00:002019-06-22 00:00:00Can Dendritic Cell Vaccination Prevent Leukemia Relapse?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-21 / J. Cell. Physiol. 2020 Jan;235(1):74-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-21 / J. Cell. Physiol. 2020 Jan;235(1):74-862019-06-21 00:00:002020-05-06 13:50:39Dendritic cell/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape
